Analyst consensus rating
Cytokinetics Analyst Rating: Strong Buy
Direct answer
Cytokinetics's consensus rating is Strong Buy.
20 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $109.40.
Forecast evidence checked October 17, 2026.
Get free Cytokinetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $61.95
- Average price target
- $109.40
- High price target
- $146.00
- Low price target
- $85.00
- Low target gap
- +37.2%
- Target upside
- +76.6%
- High target gap
- +135.7%
- Target range width
- 98.5%
- Consensus rating
- Strong Buy
- Analysts
- 20
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cytokinetics?
Cytokinetics has a verified Strong Buy consensus. The same dataset has an average price target of $109.40.
How far are Cytokinetics's low and high targets from the recorded price?
The low target implies +37.2%, while the high target implies +135.7%.
How many analysts are included in Cytokinetics's consensus?
The verified consensus includes 20 analysts.
How is Cytokinetics's target upside or downside calculated?
The average target of $109.40 is divided by the recorded price of $61.95, then one is subtracted to produce +76.6%. This does not guarantee a future return.
When was Cytokinetics's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.